Did you know that labeling and artwork errors are responsible for almost half of all product recalls in the pharmaceutical industry? This alarming statistic highlights the significant impact that these errors can have on the pharmaceutical supply chain. Healthcare professionals, pharmaceutical manufacturers, and regulatory bodies must address this issue proactively. These errors can lead to delays, non-compliance, and financial losses. Thus, in today’s competitive landscape effective artwork management process is crucial for brands.
Unlocking the potential of a ground-breaking pharmaceutical product requires meticulous attention to detail, especially when it comes to artwork management. In the ever-evolving landscape of regulatory compliance, where success hinges on flawless execution, there is no room for error. But why Right-First-Time Artwork?
With digitalization taking up the world, some might say that paper leaflets are an outdated approach. Paper leaflet copies can become outdated whenever new safety or effectiveness information is released, making it challenging for manufacturers to update their leaflets.
Artwork is a powerful branding tool in the pharmaceutical industry as it helps organizations create the correct brand perceptions. A survey conducted in late 2017 revealed that 60% of consumers are likely to reject a product if the label does not provide enough product information, while inadequate pictures and small text deter 37% of the end-users.
With serialization legislation introduced in two (02) major drug markets, namely, the USA and the EU, the pharma industry is being forced to take action on a large scale. On the other side, people are slowly realizing the benefits that serialization could bring in terms of patient safety and supply chain management. The mandates to serialize drugs are driven in large part by a need to secure supply chains.